BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/10/2022 1:14:37 PM | Browse: 815 | Download: 1936
 |
Received |
|
2022-03-20 01:14 |
|
Peer-Review Started |
|
2022-03-20 01:15 |
|
First Decision by Editorial Office Director |
|
2022-04-17 03:17 |
|
Return for Revision |
|
2022-04-17 03:17 |
|
Revised |
|
2022-04-26 03:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-01 03:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-07-06 04:23 |
|
Articles in Press |
|
2022-07-06 04:23 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-26 00:28 |
|
Publish the Manuscript Online |
|
2022-08-10 13:14 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Ye Zhang, Shuai Liu and Ming Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ming Yang, DVM, PhD, Postdoctoral Fellow, Department of Surgery, University of Missouri, Roy Blunt NextGen Precision Health Building, Room 2203 1030 Hitt Street, Columbia, MO 65211, United States. yangmin@health.missouri.edu |
| Key Words |
COVID-19; SARS-CoV-2; Gut microbiota; Pancreatic cancer; Interleukin-6; Interleukin-8; Interleukin-10; Monoclonal antibodies; Modulatory treatment |
| Core Tip |
Pancreatic cancer (PC) is a leading cause of cancer-associated death worldwide. Currently, the pathogenesis of this disease is complicated without efficient therapy. Coronavirus disease 2019 (COVID-19) disease exacerbates the challenge of PC patients. The gut microbiome serves as a critical connector between viral infection and PC through the regulation of host systemic immune response. Therefore, by targeting the lung-gut-pancreases axis, we can modulate both cytokine storm and inflammation in patients with PC and COVID-19 infection. |
| Publish Date |
2022-08-10 13:14 |
| Citation |
Zhang CY, Liu S, Yang M. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World J Gastrointest Oncol 2022; 14(8): 1456-1468
|
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i8/1456.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i8.1456 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
